Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors-Reference-Cited by-同舟云学术

Combination Immunotherapy with CAR T Cells and Checkpoint Blockade for the Treatment of Solid Tumors

Published:2019-11 Issue:5 Volume:36 Page:471-482
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Grosser Rachel,Cherkassky Leonid,Chintala Navin,Adusumilli Prasad S.

Funder

National Institutes of Health

U.S. Department of Defense

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference123 articles.

1. Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity;Adusumilli;Sci. Transl. Med.,2014

2. A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy [abstract];Adusumilli,2019

3. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

4. Robust antitumor responses result from local chemotherapy and CTLA-4 blockade;Ariyan;Cancer Immunol. Res.,2018

5. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma;Azimi;J. Clin. Oncol.,2012

Cited by 268 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Modifying CAR-T cells with anti-checkpoints in cancer immunotherapy: A focus on anti PD-1/PD-L1 antibodies;Life Sciences;2024-02

2. Clear cell renal cell carcinoma: immunological significance of alternative splicing signatures;Frontiers in Oncology;2024-01-15

3. Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies;Journal of Biomedical Science;2024-01-12

4. Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial;Nature Cancer;2024-01-12

5. The Power of Three: Nanomaterials for Natural Killer (NK) Cell Immunoengineering Maximize Their Potency if They Exploit Multireceptor Stimulation;Advanced Healthcare Materials;2024-01-04